AbbVie S.r.l. (primary and secondary packaging, batch release)

The drug is prescribed for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis), atopic dermatitis, ulcerative colitis, and Crohn's disease.

Dosage form: tablets, film-coated, prolonged release

ATC: L04AF03